Comparaison de l’IRM de diffusion corps entier et du bilan radiologique standard dans le staging du myélome

Autor: Narquin, S., Ingrand, P., Azais, I., Delwail, V., Tomowiak, C., Vialle, R., Boucecbi, S., Tasu, J.-P.

Publikováno v: In Journal de Radiologie diagnostique et interventionnelle June 2013 94(6):645-652

Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.

Autor: Dumontet C; Hospices Civils de Lyon, Lyon, France.; CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France., Demangel D; Hospices Civils de Lyon, Lyon, France., Galia P; Hospices Civils de Lyon, Lyon, France., Karlin L; Hospices Civils de Lyon, Lyon, France., Roche L; Hospices Civils de Lyon, Lyon, France., Fauvernier M; Hospices Civils de Lyon, Lyon, France., Golfier C; Hospices Civils de Lyon, Lyon, France., Laude MC; Hospices Civils de Lyon, Lyon, France., Leleu X; Hematology Department, CHU Poitiers, Poitiers, France., Rodon P; Hematology Department, CH Périgueux, Périgueux, France., Roussel M; IUC-Oncopôle, Toulouse, France., Azaïs I; Hematology Department, CHU Poitiers, Poitiers, France., Doyen C; UCL Mont-Godinne, Louvain, Belgium., Slama B; Clinical Hematology Department, CH Avignon, Avignon, France., Manier S; Hematology Department, CHRU, Lille, France., Decaux O; Hematology Department, CHU Rennes, Inserm UMR1236, Rennes, France., Pertesi M; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France.; Department of Laboratory Medicine, Hematology and Transfusion Medicine, Lund, Sweden., Beaumont M; Hematology Department, CHU Dunkerque, Dunkerque, France., Caillot D; Clinical Hematology Department, Hôpital F. Mitterrand, CHU Dijon, Dijon, France., Boyle EM; Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Cliquennois M; Hospitals Organization of Catholic Institute, Lille, France., Cony-Makhoul P; CH Annecy Genevois, Pringy, France., Doncker AV; Private Hospital Sévigné, Cesson-Sévigné, France., Dorvaux V; Clinical Hematology Department, CHR Metz-Thionville, Metz-Thionville, France., Petillon MO; Intergroupe Francophone du Myélome, France., Fontan J; Hematology Department, CHU Besançon, Besançon, France., Hivert B; Hospitals Organization of Catholic Institute, Lille, France., Leduc I; Hematology Department, CH d'Abbeville, Abbeville, France., Leyronnas C; Daniel Hollard Institute-GHM-Grenoble, Grenoble, France., Macro M; Hematology Department, CHU Caen, Caen, France., Maigre M; Internal Medicine Department, CH Chartres, Chartres, France., Mariette C; Hematology Department, CHU Grenoble, Grenoble, France., Mineur P; Clinical Hematology Department, Grand Hôpital de Charleroi, Charleroi, Belgium., Rigaudeau S; Hematology Department, CH Versailles, Versailles, France., Royer B; Clinical Hematology and Cell Therapy Department, Amiens, France., Vincent L; Clinical Hematology Department, CHU Montpellier, France., Mckay J; Genetic Cancer Susceptibility, International Agency for Research on Cancer, Lyon, France., Perrial E; CRCL, UMR INSERM 1052/CNRS 5286/University of Lyon-France, Lyon, France., Garderet L; HU PITIE SALPETRIERE APHP, Paris, France.; Centre de Recherche Saint-Antoine-Team Hematopoietic and Leukemic Development, Sorbonne Université-INSERM, UMR_S 938, Paris, France.

Publikováno v: American journal of hematology [Am J Hematol] 2023 Feb; Vol. 98 (2), pp. 264-271. Date of Electronic Publication: 2023 Jan 01.

Culture-Negative Native Vertebral Osteomyelitis: A Narrative Review of an Underdescribed Condition.

Autor: Alavi, Seyed Mohammad Amin¹ (AUTHOR) sma.alavi94@gmail.com, Petri, Francesco^2,3 (AUTHOR) andrea.gori@unimi.it, Mahmoud, Omar K.² (AUTHOR) omarmhmud1@gmail.com, Igwilo-Alaneme, Rita² (AUTHOR) igwilo-alaneme.rita@mayo.edu, El Zein, Said² (AUTHOR) selzein20@gmail.com, Nassr, Ahmad N.⁴ (AUTHOR) nassr.ahmad@mayo.edu, Gori, Andrea^3,5 (AUTHOR), Berbari, Elie F.² (AUTHOR) berbari.elie@mayo.edu

Publikováno v: Journal of Clinical Medicine. Oct2024, Vol. 13 Issue 19, p5802. 16p.

Continuous Treatment With Lenalidomide and Low-Dose Dexamethasone for Patients With Transplant-Ineligible Newly Diagnosed Multiple Myeloma in the First Trial: Impact of Age

Autor: Hulin, C., Shustik, C., Belch, A., Petrucci, M.T., Dührsen, U., Lu, J., Song, K., Rodon, P., Garderet, L., Hunter, H., Azais, I., Eek, R., Macro, M., Dakhil, S., Houck, V., Chen, G., Ervin-Haynes, A., Offner, F., Dimopoulos, M.A., Facon, T.

Publikováno v: In Clinical Lymphoma Myeloma and Leukemia September 2015 15 Supplement 3:e130-e131

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.